Results 331 to 340 of about 104,116 (405)

Comparative effectiveness of missed dose protocols of opioid agonist treatment in British Columbia, Canada: protocol for a population-based target trial emulation. [PDF]

BMJ Open
Mondol MH, Min JE, Kurz M, Zanette M, Hossain MB, Bach P, Gustafson P, Platt RW, Seaman S, Socías ME, Nosyk B, Karim ME.   +11 more
europepmc   +1 more source

Cost-Sharing and Buprenorphine Prescription Dispensing.

JAMA Health Forum
Nguyen TD, Conti RM, Lagisetty P, Bohnert ASB, Nuliyalu U, Chua KP.   +5 more
europepmc   +1 more source

Astrocytes and Astrocyte-Derived Extracellular Conduits in Opiate-Mediated Neurological Disorders. [PDF]

Cells
Ray S, Datta S, Saha A, Sil S.
europepmc   +1 more source

Responding to reports of nitazene toxicity in Australia

Medical Journal of Australia, Volume 222, Issue 5, Page 216-219, March 2025.
Brendan Clifford, Amy Peacock, Krista J Siefried, John Gobeil, Jennifer L Smith, Nadine Ezard   +5 more
wiley   +1 more source

Duration of Methadone and Buprenorphine-Naloxone Treatment.

JAMA Netw Open
Kleinman RA, Kurdyak P.
europepmc   +1 more source

Health Services Usage in Patients Receiving Buprenorphine for Opioid Use Disorder or Long-Term Opioid Therapy for Chronic Pain: Retrospective Cohort Study. [PDF]

JMIR Form Res
Savitz ST, Stevens MA, Nath B, D'Onofrio G, Melnick ER, Jeffery MM.   +5 more
europepmc   +1 more source

Characterization of inflammatory and neurofunctional markers in the context of early life stress among a clinical sample of people maintained on buprenorphine for opioid use disorder. [PDF]

Brain Behav Immun Health
Marcus MM, Pignatello T, Howell P, Chen S, Moeller FG, Neigh GN, Martin CE.   +6 more
europepmc   +1 more source

Non-Prescribed Use of Opioid Agonist Medications and Associations with Non-Fatal Overdoses: A Repeated Cross-Sectional Study across a Decade of Reduced Monitoring.

Eur Addict Res
Bretteville-Jensen AL, Nesse L.
europepmc   +1 more source